BI 443651 Multiple Rising Dose in Healthy Volunteers Followed by a Cross-over in CF Subjects
Status:
Completed
Trial end date:
2018-08-29
Target enrollment:
Participant gender:
Summary
The objective of this study is to investigate the safety, tolerability, and pharmacokinetics
of BI 443651 in male and female healthy volunteers and subjects with Cystic Fibrosis (CF).